Dexcom (DXCM) Share-based Compensation (2010 - 2026)

Dexcom (DXCM) has 17 years of Share-based Compensation data on file, last reported at $35.8 million in Q1 2026.

• On a quarterly basis, Share-based Compensation changed N/A year-over-year to $35.8 million in Q1 2026; TTM through Mar 2026 was $195.4 million, a 48.71% increase from a year earlier, with the FY2025 full-year figure at $159.6 million, down 6.34% from the prior year.
• Share-based Compensation for Q1 2026 stood at $35.8 million, up from $35.0 million in the prior quarter.
• Over the last five years, Share-based Compensation for DXCM reached as high as $79.5 million in Q2 2025 and fell as low as $29.1 million in Q1 2022.
• Historically, Share-based Compensation has averaged $40.2 million across 5 years, with a median of $37.9 million in 2023.
• On a YoY basis, Share-based Compensation climbed as much as 6420.0% in 2022 and fell as far as 59.84% in 2022.
• Year by year, Share-based Compensation stood at $34.0 million in 2022, then advanced by 8.53% to $36.9 million in 2023, then gained by 17.34% to $43.3 million in 2024, then fell by 19.17% to $35.0 million in 2025, then advanced by 2.29% to $35.8 million in 2026.
• Per Business Quant data, the three most recent Share-based Compensation figures were $35.8 million in Q1 2026, $35.0 million in Q4 2025, and $45.1 million in Q3 2025.